Japan PMDA's investigation results for five products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1686卷 / 1期

关键词：

D O I：

10.1007/s40278-018-41069-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 50 条

[21] PMDA recommends package insert revisions for five products
Reactions Weekly, 2020, 1826 (1) : 4 - 4
[22] PMDA investigation results from September 2018
Reactions Weekly, 2018, 1722 (1) : 2 - 2
[23] Revised precautions issued by Japan's PMDA
Reactions Weekly, 2016, 1620 (1) : 5 - 5
[24] PMDA releases six summary of investigation results
Reactions Weekly, 2016, 1626 (1) : 6 - 6
[25] PMDA presents investigation results for hepatitis C therapies
Reactions Weekly, 2016, 1603 (1) : 5 - 5
[26] PMDA releases investigation results for six primary drugs
Reactions Weekly, 2016, 1585 (1) : 5 - 5
[27] PMDA releases investigation results for 6 primary drugs
Reactions Weekly, 2015, 1550 (1) : 5 - 5
[28] MHLW/PMDA investigation results: June 2019 highlights
Reactions Weekly, 2019, 1757 (1) : 3 - 3
[29] Japan's PMDA reviews renal contraindications for metformin
Reactions Weekly, 2019, 1767 (1) : 1 - 1
[30] The PMDA's view on the limited pipeline of nephrology drugs in Japan
Tanaka, Mototsugu
Ikuma, Mutsuhiro
KIDNEY INTERNATIONAL, 2021, 100 (01) : 241 - 242

← 1 2 3 4 5 →